mice, PDBu did not further increase vasopressin-stimulated urea permeability. Western blot analysis showed that expression of the UT-A1 urea transporter in IMCDs was increased in response to vasopressin in wild-type mice as well as PKC␣ Ϫ/Ϫ mice. Hypertonicity increased UT-A1 phosphorylation in wild-type mice but not in PKC␣ Ϫ/Ϫ mice. We conclude that PKC␣ mediates hypertonicitystimulated urea transport but is not necessary for vasopressin stimulation of urea permeability in mouse IMCDs.
vasopressin; phorbol ester; urine concentration; PKA UREA PLAYS AN IMPORTANT ROLE in the urine concentrating mechanism. The antidiuretic hormone vasopressin (AVP) is well recognized as a major regulator of urea permeability. Vasopressin stimulates expression and phosphorylation of the UT-A urea transporters UT-A1 and UT-A3 in rat inner medullary collecting ducts (IMCDs). Vasopressin regulates urea permeability and urea transporter activity through cAMP-dependent signaling pathways involving protein kinase A (PKA) and the exchange protein activated by cAMP, Epac (16) . Interestingly, evidence has emerged showing that a vasopressin-independent activator, hypertonicity, clearly contributes to regulation of urea transport, thereby regulating water balance. During antidiuresis, the inner medulla is hypertonic, which is necessary for the kidneys to concentrate urine efficiently. Previous studies have shown that hypertonicity increases intracellular calcium (3) . Increasing the osmolality of the tubule environment with NaCl increases urea permeability in isolated perfused rat IMCDs (17) . The increase in urea permeability stimulated by hypertonicity is diminished by the presence of the protein kinase C (PKC) blockers chelerythrine and rottlerin. Treatment of rat IMCDs with a PKC stimulator, phorbol dibutyrate (PDBu), further increases urea permeability above the vasopressin-stimulated level (17) . All of these findings suggest that hypertonicity independently regulates urea permeability through a calcium-dependent PKC signaling pathway. However, it is unclear which PKC isoform is involved in this process.
PKC is a general designation that actually refers to a family of serine/threonine kinases consisting of three subgroups: the conventional PKC isozymes that require diacylglycerol (DAG) and Ca 2ϩ for activation (␣, ␤I, ␤II, and ␥); the novel forms that require only DAG (␦, ε, , and ), and the atypical PKC forms ( and ) that require neither (1, 2, 4, 5, 10, 11, 14) . Recently, the calcium-dependent PKC isoform, PKC␣, has become a focus of studies on urine concentration. In the kidney, PKC␣ is widely expressed in the glomerulus, the cortical collecting duct intercalated cells, and the medullary collecting duct (11) . Studies of PKC␣-deficient (PKC␣ Ϫ/Ϫ ) mice reveal that they display a greater urinary flow rate (18) and lower urinary osmolality (8, 18 ) than wild-type mice. We showed that hypertonicity fails to induce UT-A1 phosphorylation in IMCD suspensions from PKC␣ Ϫ/Ϫ mice (8) . These findings support the potential role of PKC␣ in the regulation of urea permeability. However, direct functional analysis of urea permeability in IMCDs from PKC␣ Ϫ/Ϫ mice has not previously been reported.
Mouse IMCD perfusion is an extremely difficult technique but the only one that can address the functional question of the physiological role of PKC␣ in the kidney. We have perfected this technique and collected data to support our hypothesis that PKC␣ is involved in the regulation of urea permeability under hypertonic conditions in IMCDs. In the present study, we examined whether 1) wild-type mice respond to hypertonicity similar to rats; 2) stimulation of urea permeability by hypertonicity or a PKC stimulator (PDBu) was abolished in PKC␣ Ϫ/Ϫ mice; and 3) vasopressin regulation of urea permeability is intact in the absence of PKC␣.
METHODS

Animals.
All animal protocols were approved by the Emory University Institutional Animal Care and Use Committee. C57B6 mice (control wild-type mice) were purchased from Charles River Laboratories, Wilmington, MA, and PKC␣ knockout mice, originally the generous gift of Dr. Jeff Molkentin, Cincinnati Children's Hospital, were bred at Emory's mouse breeding facility. For tubule perfusion experiments, mice were injected with furosemide (5 mg/kg body wt) 30 min prior to euthanasia. Kidneys were dissected to remove inner medullas (IMs). Single tubules from the terminal IMCD were microdissected at 17°C. For Western blot and autoradiographic analysis of proteins, some mice were treated with deamino-Cys1, D-Arg8]-Vasopressin (dDAVP) (0.5 ng/h) for 3 days via osmotic minipump (Alzet, Dureet) prior to euthanasia. Kidneys were removed from treated or nontreated mice and IMs were dissected and used either for metabolic labeling and immunoprecipitation or for direct Western blot analysis of whole cell lysates.
Tubule perfusion. Single IMCDs were dissected, mounted on glass pipettes, and perfused as described previously (12, 13, 17) . In general, 45 min after warming of the tubules to 37°C in the bath solution, three 1-min collections of 30 -50 nl/min were made.
To measure the response to treatments, buffers were changed or treatments were added to the bath, tubules were allowed to equilibrate for 15 min, then three further collections were made and urea concentration was assessed by ultramicrofluorometry. Urea permeability was calculated as described previously (12, 13, 17) .
To subject the tubules to hypertonic conditions, the osmolalities of both the perfusate and the bath were increased from 290 to 690 mosmol/kgH 2O by adding 200 mM NaCl. To determine whether the PKA signaling pathway is intact in both C57B6 mice and PKC␣ Ϫ/Ϫ mice, the following experiments were carried out: first, basal urea permeability was measured followed by sequential addition of 10 M forskolin or 200 pM vasopressin in the bath. Next, the tubules were perfused initially with 200 pM vasopressin and then with the PKC stimulator PDBu (200 nM) in the presence of vasopressin, and urea permeability was measured.
Western blot analysis. Identical samples of whole inner medullary protein lysate (20 g/lane) were size separated by SDS-PAGE on 10% gels then electroblotted to polyvinylidene difluoride membranes (Immobilon, Millipore, Bedford, MA). Blots were blocked with 5% nonfat dry milk in Tris-buffered saline (TBS: 20 mM Tris·HCl, 0.5 M NaCl, pH 7.5) then incubated with primary antibodies overnight at 4°C. Attached primary antibodies were identified by use of Alexa Fluor 680-linked anti-rabbit IgG (Molecular Probes, Eugene, OR) and visualized by infrared detection with the LICOR Odyssey protein analysis system (Lincoln, NE).
Phosphorylation. Metabolic labeling with [ 32 P]orthophosphate was performed as previously described (19) . After a 3-h incubation of IM pieces in phosphate-free DMEM with 0.15 mCi/ml [ 32 P]orthophosphate to radiolabel the ATP pool, 200 mM NaCl was added to the radiolabeling buffer for an additional 30 min. NaCl was used to induce hypertonicity, similar to the perfused tubule studies. Following treatments, pieces were washed free of unincorporated 32 P with phosphatefree DMEM, and 32 P-labeled UT-A1 was immunoprecipitated as previously described (6) . Precipitated proteins were separated by SDS-PAGE and radiolabeled UT-A1 was determined by autoradiography of the dried gel.
Statistics. All data are presented as means Ϯ SE. Data from tubule perfusion studies were analyzed by a paired Student's t-test or repeated-measures ANOVA, depending on whether two conditions or more than two conditions were assessed in each tubule. Each tubule serves as its own control, allowing a paired analysis of the data. Other data were analyzed by a Student's t-test or ANOVA, depending on whether two conditions or more than two conditions were assessed. The criterion for statistical significance is P Ͻ 0.05.
RESULTS
Urea permeability under hypertonic conditions. Increasing the osmolality of the perfusate and bath solutions from 290 to 690 mosmol/kgH 2 O resulted in a significant increase in urea permeability from 25 Ϯ 6 to 53 Ϯ 4 ϫ 10 Ϫ5 cm/s (n ϭ 4, P Ͻ 0.01; Fig. 1A ) in IMCDs from wild-type mice. In contrast, increasing the osmolality did not change urea permeability significantly [from 39 Ϯ 8 to 42 Ϯ 9 ϫ 10 Ϫ5 cm/s, n ϭ 4, P ϭ not significant (NS); after PDBu treatment (31 Ϯ 5 ϫ 10 Ϫ5 cm/s, n ϭ 4, P ϭ NS) was not different from vasopressin-stimulated urea permeability (32 Ϯ 6 ϫ 10 Ϫ5 cm/s, n ϭ 4) in IMCDs of PKC␣ Ϫ/Ϫ mice (Fig. 2B) .
Urea permeability stimulated by forskolin. To determine whether the cAMP signaling pathway is intact in PKC␣ Ϫ/Ϫ mice, we measured urea permeability when 10 M forskolin was added to the bath. Forskolin is known to directly stimulate adenylyl cyclase and subsequently activate the cAMP signaling pathway. Urea permeability after forskolin treatment (24 Ϯ 3 ϫ 10 Ϫ5 cm/s, n ϭ 4, P Ͻ 0.01) was significantly increased from the basal urea permeability (17 Ϯ 2 ϫ 10 -5 cm/s, n ϭ 4) in PKC␣ Ϫ/Ϫ mice (Fig. 3) . Urea permeability stimulated by vasopressin. To ensure that the vasopressin signaling pathway is intact in PKC␣ Ϫ/Ϫ mice, and that the IMCDs respond to stimulation of this pathway in the PKC␣ Ϫ/Ϫ mice as they do in wild-type mice, we measured urea permeability in perfused tubules from PKC␣ Ϫ/Ϫ and wild-type mice when 200 pM vasopressin was added to the bath. Urea permeability was increased from 24 Ϯ 4 to 31 Ϯ 5 ϫ 10 Ϫ5 cm/s (n ϭ 4, P Ͻ 0.05) in IMCDs of PKC␣ Ϫ/Ϫ mice (Fig.  4B) . In IMCDs from wild-type mice, vasopressin treatment elevated urea permeability from 15 Ϯ 4 to 26 Ϯ 5 ϫ 10 Ϫ5 cm/s (n ϭ 3, P Ͻ 0.05; Fig. 4A) .
Vasopressin-stimulated UT-A1 protein abundance. Vasopressin was delivered to wild-type and PKC␣ Ϫ/Ϫ mice by minipump for 3 days, and then the UT-A1 abundance was analyzed by Western blot. Figure 5 shows that vasopressin did not cause a significant increase in UT-A1 protein abundance (28%, P ϭ NS, n ϭ 5) in wild-type mice. In contrast, vasopressin significantly increased UT-A1 protein abundance by 96% (P Ͻ 0.01, n ϭ 5) in PKC␣ Ϫ/Ϫ mice. Hypertonicity stimulated UT-A1 phosphorylation. To determine whether hypertonicity could stimulate UT-A1 phosphorylation in PKC␣ Ϫ/Ϫ mice, metabolically labeled IMCDs from wild-type or PKC␣ Ϫ/Ϫ mice were incubated with isotonic (290 mosmol/kgH 2 O) or hypertonic (690 mosmol/kgH 2 O) medium for 30 min. Figure 6A shows 32 P-UT-A1 from representative wild-type and ratio of phosphorylated UT-A1 to total UT-A1 in wild-type mice by 42% (P Ͻ 0.05, n ϭ 7; Fig. 6A ). In contrast, there was no significant increase in the ratio of phosphorylated UT-A1 to total UT-A1 in the PKC␣ Ϫ/Ϫ mice (P ϭ NS, n ϭ 4; Fig. 6B ).
DISCUSSION
Evidence has accumulated indicating that hypertonicity mediates urea permeability through a calcium-dependent PKC signaling pathway independently of vasopressin (3, 8, 17) . The present study provides the first functional evidence that PKC␣ is the calcium-dependent PKC isoform involved in the regulation of urea permeability under hypertonic conditions in mouse IMCDs.
The present study first determined whether mouse IMCDs respond to hypertonicity similar to rat IMCDs. Previous studies show that rats and mice may differ. For instance, a decrease in the abundance of UT-A1, aquaporin 2, and Na
Ϫ has been reported in response to 7-or 14-day administration of angiotensin II in Sprague-Dawley rats (9) . But no change in the abundances of these three proteins has been observed in wildtype mice that received the same treatment with angiotensin II (15) . Therefore, it is necessary to examine the species-specific difference in response to hypertonicity to extend the study of PKC-regulated urea permeability from rats to mice.
Previous studies show that hypertonicity significantly increases urea permeability in isolated perfused rat terminal IMCDs. Additional experiments also show that the PKC stimulator, PDBu, has an additive effect on urea permeability in the presence of vasopressin in rat IMCDs (17) . To explore whether these findings can be replicated in mouse models, we perfused mouse terminal IMCDs under hypertonic conditions. Hypertonicity significantly increased urea permeability in mouse IMCDs (Fig. 1A) comparable to the increases observed in rats (17) . When added to the bath, PDBu also further increased urea permeability above the vasopressin-stimulated level ( Fig. 2A) comparable to the changes in rat IMCDs (17) . These findings suggest that mouse IMCDs are a good model for the study of PKC regulated urea permeability.
Previous studies suggested that hypertonicity mediates urea permeability through a calcium-dependent PKC isoform (3, 17) . Given that PKC␣ is a calcium-dependent PKC isoform and has been reported to be involved in regulation of urine concentration, we investigated the role of PKC␣ in PKCregulated urea permeability using PKC␣-deficient (PKC␣ Ϫ/Ϫ ) mice. We showed that the hypertonicity-mediated increase in urea permeability was absent in PKC␣ Ϫ/Ϫ mice (Fig. 1B) . Treatment of the IMCDs with PDBu did not further increase urea permeability in the presence of vasopressin (Fig. 2B) . Apparently, PKC␣ Ϫ/Ϫ mice are not able to respond to hypertonicity as well as the wild-type mice ( Figs. 1 and 2 ). These data strongly support the concept that PKC␣ is the PKC isoform that mediates the increase in urea permeability under hypertonic conditions.
Vasopressin, a major regulator of urea permeability, binds to the V 2 vasopressin receptor on the basolateral membrane of IMCD cells and stimulates cAMP-dependent signaling pathways through, for example, PKA or Epac. Activation of either PKA or Epac stimulates urea permeability in rat IMCDs (16) . Our previous studies show that vasopressin synergizes with PKC to stimulate urea permeability in rat IMCDs (17) . Given the synergy between vasopressin and PKC, it was necessary for us to exclude the possibility that vasopressin regulation might be altered owing to the knockout of PKC␣. To ensure that loss of PKC␣ is solely responsible for diminished responses to hypertonicity or PDBu in PKC␣ Ϫ/Ϫ mice, we first tested whether activation of cAMP directly with forskolin was still able to stimulate urea permeability. Having verified that this pathway was intact, we proceeded to determine whether the V 2 receptor-mediated activation of cAMP was intact. Our data indicate that forskolin significantly increased urea permeability in PKC␣ Ϫ/Ϫ mice (Fig. 3) and that vasopressin increased urea permeability in wild-type mice (Fig. 4A) as well as PKC␣ Ϫ/Ϫ mice (Fig. 4B) . These two experiments combine to show that the cAMP signaling pathway is intact in the PKC␣ knockout mice.
We also tested for changes of UT-A1 urea transporter protein abundance in response to vasopressin in PKC␣ Ϫ/Ϫ mice. Like rats, wild-type mice did not show a significant increase in UT-A1 protein abundance with 3 days of vasopressin (reviewed in Ref. 7) . In contrast, PKC␣ Ϫ/Ϫ mice showed a significant increase in UT-A1 protein abundance in response to vasopressin treatment (Fig. 5) . These data clearly indicate that vasopressin regulation of urea permeability is intact, independent of knockout of PKC␣, and suggest that UT-A1 protein abundance may increase more quickly in the absence of PKC␣. Future studies will be needed to determine the mechanism for this more rapid increase in UT-A1 protein abundance.
We previously discovered that hypertonicity increased UT-A1 phosphorylation in wild-type mice but was unable to increase UT-A1 phosphorylation in the PKC␣ knockout mice, by using a solution made hypertonic by the addition of sucrose (8) . This finding suggests that UT-A1 phosphorylation by PKC may be required for the changes in urea permeability in response to hypertonicity. In the present study, we extended this finding by measuring UT-A1 phosphorylation in response to hypertonicity when NaCl was used to increase osmolality, since NaCl was used to increase osmolality in the functional experiments performed in isolated perfused tubules. NaCl is a more physiologically relevant osmole than sucrose in terms of the constituents of the inner medulla. It was important, therefore, to test the effect of NaCl on UT-A1 phosphorylation. Our data demonstrated that increasing osmolality with NaCl increased UT-A1 phosphorylation in wild-type mice (Fig. 6A ), but not in PKC␣ Ϫ/Ϫ mice (Fig. 6B) , which is consistent with the previous result from sucrose-induced hypertonicity (8) .
In conclusion, the present study shows that hypertonicityregulated urea permeability observed in rat IMCDs can be repeated in mouse IMCDs, which allows us to expand the study of hypertonicity-regulated urea permeability from rats to mice. PKC␣ mediates the hypertonicity-stimulated increase in urea permeability. The increase in urea permeability appears to be a result of an increase in UT-A1 phosphorylation. Vasopressin-regulated urea permeability remains intact in the absence of PKC␣ Ϫ/Ϫ in mice, which indirectly supports the hypothesis that hypertonicity is an independent regulator of urea permeability. Bar graph (C) shows the ratio of phosphorylated UT-A1 to total UT-A1 each experimental condition. All data are presented as means Ϯ SE, n ϭ 6/condition, *P Ͻ 0.05.
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